BC
BMY icon

Burleson & Co’s Bristol-Myers Squibb BMY Stock Holding History

Burleson & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.22M Buy
30,849
+2
+0% +$151 0.55% 55
2022
Q3 		$2.19M Sell
30,847
-7
-0% -$508 0.47% 53
2022
Q2 		$2.38M Buy
30,854
+13
+0% +$990 0.52% 47
2022
Q1 		$2.25M Buy
30,841
+203
+0.7% +$13.6K 0.36% 61
2021
Q4 		$1.91M Sell
30,638
-227
-0.7% -$13.3K 0.28% 62
2021
Q3 		$1.83M Buy
30,865
+2
+0% +$132 0.27% 59
2021
Q2 		$2.06M Sell
30,863
-5
-0% -$326 0.3% 56
2021
Q1 		$1.95M Buy
30,868
+3
+0% +$187 0.32% 53
2020
Q4 		$1.92M Hold
30,865
– – 0.33% 53
2020
Q3 		$1.97M Buy
30,865
+20
+0.1% +$1.2K 0.37% 53
2020
Q2 		$1.88M Sell
30,845
-266
-0.9% -$15.9K 0.41% 52
2020
Q1 		$1.9M Buy
31,111
+77
+0.2% +$4.71K 0.49% 51
2019
Q4 		$2.09M Buy
31,034
+450
+1% +$25.8K 0.59% 49
2019
Q3 		$1.68M Buy
30,584
+53
+0.2% +$2.49K 0.58% 46
2019
Q2 		$1.38M Hold
30,531
– – 0.58% 49
2019
Q1 		$1.48M Buy
30,531
+1,467
+5% +$73.1K 0.63% 43
2018
Q4 		$1.46M Buy
29,064
+4,947
+21% +$266K 0.75% 38
2018
Q3 		$1.29M Buy
24,117
+90
+0.4% +$5.34K 0.72% 39
2018
Q2 		$1.33M Buy
24,027
+1,047
+5% +$56.5K 0.77% 42
2018
Q1 		$1.45M Buy
22,980
+38
+0.2% +$2.44K 0.95% 36
2017
Q4 		$1.41M Buy
+22,942
New +$1.43M 0.9% 38

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Burleson & Co's BMY Position: Q4 2022 in Review

Burleson & Co increased its Bristol-Myers Squibb (BMY) stake by 0.01% in Q4 2022, buying an estimated $151 and bringing the position to 30,849 shares worth $2.22M. The position accounts for 0.55% of the portfolio, ranked #55.

Burleson & Co first reported a position in BMY in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.38M in Q2 2022. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Burleson & Co held 30,849 shares of Bristol-Myers Squibb worth $2.22M as of Q4 2022.
  • Burleson & Co bought 2 Bristol-Myers Squibb shares in Q4 2022, an estimated $151.
  • Bristol-Myers Squibb made up 0.55% of Burleson & Co's portfolio in Q4 2022, its #55 holding.
  • Burleson & Co first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 21 quarters since.
  • Burleson & Co's Bristol-Myers Squibb position peaked at $2.38M in Q2 2022.
  • 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.